Medizone and PassionBio agree on closer cooperation
PassionBio’s provides drug development, regulatory and commercial solutions for biologics, biosimilar/-better or mAb programs. Our aim is to foster cross-frontier development of your biosimilar portfolio. We ...New EU GDP Guidelines – Part II
The “Guidelines on Good Distribution Practice of Medicinal Products for Human Use” have been published 07.03.2013. But only a few months later the GDP had to be renewed. The new version 2013/C 343/01 ...Apotex Canada received its first Biosimilar registration in Europe of Amgen’s blockbuster cancer treatment filgrastim!
Apotex's version of filgrastim received regulatory approval from the European Commission. Out-of-patent filgrastim, a biologic drug branded as Neupogen by Amgen and as Grastofil by Apotex, is used to boost ...
Medizone Germany GmbH · Keltenring 15 · 82041 Oberhaching · Germany · Phone +49(0)89/12112636 · Fax +49(0)89/12112637 · Impressum · Datenschutz · Imprint · Privacy Policy